Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D3 signaling via vitamin D receptor deacetylation.

Sabir MS, Khan Z, Hu C, Galligan MA, Dussik CM, Mallick S, Stone AD, Batie SF, Jacobs ET, Whitfield GK, Haussler MR, Heck MC, Jurutka PW.

J Steroid Biochem Mol Biol. 2017 Sep;172:117-129. doi: 10.1016/j.jsbmb.2017.06.010. Epub 2017 Jun 19.

2.

Resveratrol potentiates vitamin D and nuclear receptor signaling.

Dampf Stone A, Batie SF, Sabir MS, Jacobs ET, Lee JH, Whitfield GK, Haussler MR, Jurutka PW.

J Cell Biochem. 2015 Jun;116(6):1130-43. doi: 10.1002/jcb.25070.

PMID:
25536521
3.

Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.

An BS, Tavera-Mendoza LE, Dimitrov V, Wang X, Calderon MR, Wang HJ, White JH.

Mol Cell Biol. 2010 Oct;30(20):4890-900. doi: 10.1128/MCB.00180-10. Epub 2010 Aug 23.

5.

Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.

Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA, Haussler MR, Jurutka PW.

J Nutr Biochem. 2010 Dec;21(12):1153-61. doi: 10.1016/j.jnutbio.2009.09.012. Epub 2010 Feb 12.

6.

Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.

Raval-Pandya M, Freedman LP, Li H, Christakos S.

Mol Endocrinol. 1998 Sep;12(9):1367-79.

PMID:
9731705
7.

New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.

Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK.

Bone. 1995 Aug;17(2 Suppl):33S-38S. Review.

PMID:
8579895
8.

Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.

Alimirah F, Peng X, Yuan L, Mehta RR, von Knethen A, Choubey D, Mehta RG.

Exp Cell Res. 2012 Nov 15;318(19):2490-7. doi: 10.1016/j.yexcr.2012.07.020. Epub 2012 Aug 4.

PMID:
22884583
10.

Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.

Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB.

Endocrinology. 1996 May;137(5):2001-11.

PMID:
8612541
11.

Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.

Herdick M, Steinmeyer A, Carlberg C.

Chem Biol. 2000 Nov;7(11):885-94.

12.
13.

Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression.

Deb DK, Wang Y, Zhang Z, Nie H, Huang X, Yuan Z, Chen Y, Zhao Q, Li YC.

J Biol Chem. 2011 Sep 16;286(37):32011-7. doi: 10.1074/jbc.M111.269118. Epub 2011 Jul 29.

14.

Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.

Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E.

Mol Pharmacol. 2001 Dec;60(6):1399-406.

PMID:
11723248
15.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

PMID:
9379138
16.

Heterodimer requirement for gene regulation by Vitamin D in variant OK cells.

Koszewski NJ, Rowan A.

Steroids. 2003 Apr;68(4):307-14.

PMID:
12787891
17.
18.
19.
20.

Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.

Claro da Silva T, Hiller C, Gai Z, Kullak-Ublick GA.

J Steroid Biochem Mol Biol. 2016 Oct;163:77-87. doi: 10.1016/j.jsbmb.2016.04.006. Epub 2016 Apr 20.

Supplemental Content

Support Center